Evidence map›Paper›PMID 41178464›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

NUSAP1 Recruits DAXX to Suppress HIF-Driven Triple-Negative Breast Cancer Progression.

Yating Du, Jingjing Wang, Min Wang, Yao Zhang, Miaomiao Zheng, Huiyan Li, Xuemeng Wang, Huanran Sun, Kexin Tang, Changliang Shan and 5 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. NUSAP1 Recruits DAXX to Suppress HIF-Driven Triple-Negative Breast Cancer Progression.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yating DuCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Jingjing WangCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Min WangCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Yao ZhangSchool of Medicine, Jinan University, Guangzhou, 510630, China.
Miaomiao ZhengCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Huiyan LiCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Xuemeng WangCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Huanran SunCollege of Pharmacy, Nankai University, Tianjin, 300350, China.
Kexin TangCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Changliang ShanCollege of Pharmacy, Nankai University, Tianjin, 300350, China.
Qiang ZhaoSchool of Mathematics and Statistics, Shandong Normal University, Jinan, 250014, China.
Xiaoqian MengCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Yijie WangCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Jun ZhouCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Yan ChenCollaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.ORCID https://orcid.org/0000-0003-3516-9546

Funding

National Key R&D Program of China 2021YFA1101001National Natural Science Foundation of China 32570857National Natural Science Foundation of China 82203297National Natural Science Foundation of China 82573303Natural Science Foundation of Shandong Province ZR2023MH252Shandong Excellent Young Scientists Fund Program 2022HWYQ-077Taishan Scholar Foundation of Shandong Province tsqn202306154Taishan Scholar Foundation of Shandong Province tsqn202306155
6 · The paper itself

Abstract

Nucleolar and spindle-associated protein 1 (NUSAP1) is critical for cancer progression. However, its function in cancers is context-dependent, and emerging evidence indicates that NUSAP1 possesses tumor suppressor functions, although the underlying mechanisms remain uncharted. In this study, NUSAP1 depletion is found to significantly increases the proliferation, migration, and invasion of triple-negative breast cancer (TNBC) cells in vitro and promotes TNBC progression in vivo, suggesting that NUSAP1 is a tumor suppressor in TNBC. Mechanistically, NUSAP1 bridges HIFα and the transcriptional repressor death domain-associated protein (DAXX) through its microtubule-associated domain (MAD) to recruit the methyltransferase SETDB1, thereby attenuating HIF transcriptional activity and the expression of its target genes by depositing the H3K9me3 repressive mark on hypoxia response elements (HREs). Intriguingly, an engineered MAD of NUSAP1, designated as Tumor Suppressor-MAD (TS-MAD), is developed, which effectively abrogates HIF transcriptional activity by bridging the DAXX-HIF interaction, consequently inhibiting HIF-driven TNBC progression. Moreover, NUSAP1 is identified as a novel HIF-repressed gene in TNBC cells, and its expression level shows a negative correlation with clinical outcomes in TNBC patients. These findings establish an HIF-NUSAP1 double-negative feedback loop in TNBC and validate TS-MAD as a potential therapeutic strategy for HIF-driven cancer.

Indexed as

Co-Repressor ProteinsHypoxia-Inducible Factor 1, alpha SubunitMolecular ChaperonesTriple Negative Breast NeoplasmsAnimalsCell Line, TumorCell MovementCell ProliferationDisease ProgressionFemaleGene Expression Regulation, NeoplasticHistone-Lysine N-MethyltransferaseHumansMiceMicrotubule-Associated ProteinsCo-Repressor ProteinsDAXX protein, humanHIF1A protein, humanHistone-Lysine N-MethyltransferaseHypoxia-Inducible Factor 1, alpha SubunitMicrotubule-Associated ProteinsMolecular ChaperonesNUSAP1 protein, humanDAXXHIFhypoxiaNUSAP1triple‐negative breast cancer

Identifiers

PMID41178464
PMCPMC12850156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.